PACS2 and diabetic kidney disease: Mei Xue et al. found that PACS-2 alleviated ER stress and improved tubular epithelial cell apoptosis and renal fibrosis in DKD mice by maintaining the integrity of MAMs, thus delaying DKD progression [25].